PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictors outcomes: sPAP, Resid-TR, GGTP, ascites. Site Experience Matters! PASCAL Precision➡️ 63%MildTR! @j_hausleiter @JACCJournals @escardio #TCT2024 @TCTMD https://t.co/9DlaCXqsFU
Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results From a Large European Real-World Registry.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2024 – Aug 2025Where it's discussed
-
X / Twitter33 posts
-
YouTube2 videos
-
Facebook2 posts
-
News2 articles
AI synopsis
What people are saying
The overall discussions showcase a positive reception, with posts emphasizing the procedure’s promising results and predictors, utilizing words like 'sustained,' 'significant improvements,' and 'high-risk patients.' The tone is optimistic and analytical, reflecting both interest and engagement, while focusing on clinical details that underscore the potential high impact of this research in advancing cardiovascular treatment.
Most discussions express support and positive outlooks for the study’s findings, indicating strong agreement about the benefits of transcatheter valve repair, as seen in statements like 'promising outcomes' and 'significant clinical improvements.'
There is high curiosity about the procedure’s effectiveness and predictors, demonstrated by enthusiastic language and mentions of detailed results and predictors, showing that the discussions are highly relevant to ongoing research and practice.
Several posts delve into specific factors such as predictors of residual TR, procedural success, and clinical implications, reflecting deep cognitive engagement with the material and a focus on nuances like right ventricular dilation and coaptation gaps.
While the discussions highlight the potential significance of the procedure's success and its influence on clinical decisions, they mostly emphasize future implications rather than immediate transformative impact, leading to a moderate impact score.
Abstract in brief
- This study examines the safety and effectiveness of the PASCAL transcatheter valve repair system for treating severe tricuspid regurgitation (TR) in a real-world European setting, involving over 1,000 high-risk patients with an average age of 79 years.
- The results show that the procedure had a high success rate, with 85% of procedures successful and 87% of cases reducing TR to moderate severity, and around 83% of patients experienced significant clinical improvements, including better heart function and symptoms.
- Key factors predicting residual TR after the procedure included coaptation gaps, tenting height, presence of transvalvular leads, right ventricular dilation, and massive baseline TR, which could influence patient outcomes and procedural planning.]
Top posts
Most liked on X and Bluesky#TCT2024: @j_hausleiter, and team present 1-year results from the PASTE registry, which shows that T-TEER is safe and effective at reducing #TricuspidRegurgitation. https://t.co/wnpAO38H8A #JACC #vhdTR #TEER #CardioX https://t.co/ExLo88ALJA
Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results from Large European Real-World Registry PASCAL system treats severe TR in high-risk patients offering sustained TR reduction and significant clinical improvements at 1-year follow-up https://t.co/i4d6LQ7gTs https://t.co/W3iaUqCe5m
(10/13) Lastly, Dr. @j_hausleiter and colleagues publish results from the PASTE registry to offer new evidence for the PASCAL system: https://t.co/b9Rp8kj4uE #JACC #vhdTR #TEER https://t.co/rB3FD26O9B
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
All mentions
Improving Quality of Life with Transcatheter Tricuspid Valve Replacement
In this JACC Masterclass, Aakriti Gupta MD FACC and Martin B Leon MD FACC discuss the impact of severe tricuspid regurgitation on health status and the TRISCEND II trial findings. They highlight significant improvements…
One-Year Outcomes of Transcatheter Tricuspid Valve Repair Using PASCAL System
This study evaluates the safety and effectiveness of the PASCAL transcatheter valve repair system in high-risk patients with severe tricuspid regurgitation, showing high success rates and sustained symptom improvement…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
1-year results from a large European study show promising outcomes for transcatheter valve repair in treating tricuspid regurgitation. #HeartHealth #MedicalResearch https://t.co/aWW6veTwvH https://t.co/yzCMn7VPrK
نتائج السنة الأولى من دراسة أوروبية كبيرة تظهر نتائج واعدة لإصلاح الصمام عبر القسطرة في علاج الارتجاع الثلاثي الشرفي. #صحة_القلب #البحث_الطبي https://t.co/ZPti6wmWUX https://t.co/nrATZrWL4w
(10/13) Lastly, Dr. @j_hausleiter and colleagues publish results from the PASTE registry to offer new evidence for the PASCAL system: https://t.co/b9Rp8kj4uE #JACC #vhdTR #TEER https://t.co/rB3FD26O9B
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results From PASTE | JACC | TCT 2024 American College of Cardiology https://t.co/9jqt3hMnhv
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @drbennisahmed: Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results from Large European Real-World Registry PASCAL s…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results from Large European Real-World Registry PASCAL system treats severe TR in high-risk patients offering sustained TR reduction and significant clinical improvements at 1-year follow-up https://t.co/i4d6LQ7gTs https://t.co/W3iaUqCe5m
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
RT @hahn_rt: PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictor…
PASTE Registry (PASCAL T-TEER) https://t.co/lc0FAzdaTi Predictors Residual-TR: gap, tenting, CIED, RVDil, 4/5+ TR. Predictors outcomes: sPAP, Resid-TR, GGTP, ascites. Site Experience Matters! PASCAL Precision➡️ 63%MildTR! @j_hausleiter @JACCJournals @escardio #TCT2024 @TCTMD https://t.co/9DlaCXqsFU
RT @JACCJournals: #TCT2024: @j_hausleiter, and team present 1-year results from the PASTE registry, which shows that T-TEER is safe and eff…
RT @JACCJournals: #TCT2024: @j_hausleiter, and team present 1-year results from the PASTE registry, which shows that T-TEER is safe and eff…
RT @JACCJournals: #TCT2024: @j_hausleiter, and team present 1-year results from the PASTE registry, which shows that T-TEER is safe and eff…
RT @JACCJournals: #TCT2024: @j_hausleiter, and team present 1-year results from the PASTE registry, which shows that T-TEER is safe and eff…
#TCT2024: @j_hausleiter, and team present 1-year results from the PASTE registry, which shows that T-TEER is safe and effective at reducing #TricuspidRegurgitation. https://t.co/wnpAO38H8A #JACC #vhdTR #TEER #CardioX https://t.co/ExLo88ALJA